This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2008 Sep 15;47(6):856-7; author reply 857-8.

doi: 10.1086/591283.

Moxifloxacin monotherapy in severe pneumonia: do we really need it?

Prasanta Raghab Mohapatra, Monica Gupta, Ashok K Janmeja

PMID: 18713035
DOI: 10.1086/591283

Comment

Moxifloxacin monotherapy in severe pneumonia: do we really need it?

Prasanta Raghab Mohapatra et al. Clin Infect Dis. 2008.

. 2008 Sep 15;47(6):856-7; author reply 857-8.

doi: 10.1086/591283.

Authors

Prasanta Raghab Mohapatra, Monica Gupta, Ashok K Janmeja

PMID: 18713035
DOI: 10.1086/591283

No abstract available

PubMed Disclaimer

Comment on

Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.
Torres A, Garau J, Arvis P, Carlet J, Choudhri S, Kureishi A, Le Berre MA, Lode H, Winter J, Read RC; MOTIV (MOxifloxacin Treatment IV) Study Group. Torres A, et al. Clin Infect Dis. 2008 May 15;46(10):1499-509. doi: 10.1086/587519. Clin Infect Dis. 2008. PMID: 18419482 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems